113 related articles for article (PubMed ID: 38892327)
1. Lead Decreases Bone Morphogenetic Protein-7 (BMP-7) Expression and Increases Renal Cell Carcinoma Growth in a Sex-Divergent Manner.
Grunz EA; Anderson H; Ernst RM; Price S; Good D; Vieira-Potter V; Parrish AR
Int J Mol Sci; 2024 Jun; 25(11):. PubMed ID: 38892327
[TBL] [Abstract][Full Text] [Related]
2. Estrogen inhibits renal cell carcinoma cell progression through estrogen receptor-β activation.
Yu CP; Ho JY; Huang YT; Cha TL; Sun GH; Yu DS; Chang FW; Chen SP; Hsu RJ
PLoS One; 2013; 8(2):e56667. PubMed ID: 23460808
[TBL] [Abstract][Full Text] [Related]
3. Androgen receptor decreases renal cell carcinoma bone metastases via suppressing the osteolytic formation through altering a novel circEXOC7 regulatory axis.
Gong D; Sun Y; Guo C; Sheu TJ; Zhai W; Zheng J; Chang C
Clin Transl Med; 2021 Mar; 11(3):e353. PubMed ID: 33783995
[TBL] [Abstract][Full Text] [Related]
4. Androgen receptor (AR) suppresses miRNA-145 to promote renal cell carcinoma (RCC) progression independent of VHL status.
Chen Y; Sun Y; Rao Q; Xu H; Li L; Chang C
Oncotarget; 2015 Oct; 6(31):31203-15. PubMed ID: 26304926
[TBL] [Abstract][Full Text] [Related]
5. C1QBP Regulates YBX1 to Suppress the Androgen Receptor (AR)-Enhanced RCC Cell Invasion.
Yue D; Wang Y; Sun Y; Niu Y; Chang C
Neoplasia; 2017 Feb; 19(2):135-144. PubMed ID: 28107702
[TBL] [Abstract][Full Text] [Related]
6. Dihydrotestosterone promotes kidney cancer cell proliferation by activating the STAT5 pathway via androgen and glucocorticoid receptors.
Pak S; Kim W; Kim Y; Song C; Ahn H
J Cancer Res Clin Oncol; 2019 Sep; 145(9):2293-2301. PubMed ID: 31401673
[TBL] [Abstract][Full Text] [Related]
7. Intracrine androgen biosynthesis in renal cell carcinoma.
Lee GT; Han CS; Kwon YS; Patel R; Modi PK; Kwon SJ; Faiena I; Patel N; Singer EA; Ahn HJ; Kim WJ; Kim IY
Br J Cancer; 2017 Mar; 116(7):937-943. PubMed ID: 28253524
[TBL] [Abstract][Full Text] [Related]
8. Inactivation of bone morphogenetic protein 2 may predict clinical outcome and poor overall survival for renal cell carcinoma through epigenetic pathways.
Mitsui Y; Hirata H; Arichi N; Hiraki M; Yasumoto H; Chang I; Fukuhara S; Yamamura S; Shahryari V; Deng G; Saini S; Majid S; Dahiya R; Tanaka Y; Shiina H
Oncotarget; 2015 Apr; 6(11):9577-91. PubMed ID: 25797254
[TBL] [Abstract][Full Text] [Related]
9. Bone morphogenetic protein 7 is expressed in prostate cancer metastases and its effects on prostate tumor cells depend on cell phenotype and the tumor microenvironment.
Morrissey C; Brown LG; Pitts TE; Vessella RL; Corey E
Neoplasia; 2010 Feb; 12(2):192-205. PubMed ID: 20126477
[TBL] [Abstract][Full Text] [Related]
10. Androgen receptor (AR) signaling promotes RCC progression via increased endothelial cell proliferation and recruitment by modulating AKT → NF-κB → CXCL5 signaling.
Guan Z; Li C; Fan J; He D; Li L
Sci Rep; 2016 Nov; 6():37085. PubMed ID: 27848972
[TBL] [Abstract][Full Text] [Related]
11. LncRNA-SARCC suppresses renal cell carcinoma (RCC) progression via altering the androgen receptor(AR)/miRNA-143-3p signals.
Zhai W; Sun Y; Guo C; Hu G; Wang M; Zheng J; Lin W; Huang Q; Li G; Zheng J; Chang C
Cell Death Differ; 2017 Sep; 24(9):1502-1517. PubMed ID: 28644440
[TBL] [Abstract][Full Text] [Related]
12. HOTAIR and androgen receptor synergistically increase GLI2 transcription to promote tumor angiogenesis and cancer stemness in renal cell carcinoma.
Bai JY; Jin B; Ma JB; Liu TJ; Yang C; Chong Y; Wang X; He D; Guo P
Cancer Lett; 2021 Feb; 498():70-79. PubMed ID: 33157157
[TBL] [Abstract][Full Text] [Related]
13. Increased Expression of Androgen Receptor mRNA in Human Renal Cell Carcinoma Cells is Associated with Poor Prognosis in Patients with Localized Renal Cell Carcinoma.
Ha YS; Lee GT; Modi P; Kwon YS; Ahn H; Kim WJ; Kim IY
J Urol; 2015 Nov; 194(5):1441-8. PubMed ID: 25796113
[TBL] [Abstract][Full Text] [Related]
14. Knockdown of ALPK2 blocks development and progression of renal cell carcinoma.
Jiang J; Han P; Qian J; Zhang S; Wang S; Cao Q; Shao P
Exp Cell Res; 2020 Jul; 392(2):112029. PubMed ID: 32330508
[TBL] [Abstract][Full Text] [Related]
15. Expression of bone morphogenetic protein-7, its receptors and Smad1/5/8 in normal human kidney and renal cell cancer.
Markić D; Celić T; Spanjol J; Grsković A; Bobinac D; Fuckar Z
Coll Antropol; 2010 Apr; 34 Suppl 2():149-53. PubMed ID: 21302714
[TBL] [Abstract][Full Text] [Related]
16. Androgen receptor regulates ASS1P3/miR-34a-5p/ASS1 signaling to promote renal cell carcinoma cell growth.
Wang K; Sun Y; Guo C; Liu T; Fei X; Chang C
Cell Death Dis; 2019 Apr; 10(5):339. PubMed ID: 31000693
[TBL] [Abstract][Full Text] [Related]
17. BMP-2 inhibits tumor-initiating ability in human renal cancer stem cells and induces bone formation.
Wang L; Park P; La Marca F; Than KD; Lin CY
J Cancer Res Clin Oncol; 2015 Jun; 141(6):1013-24. PubMed ID: 25431339
[TBL] [Abstract][Full Text] [Related]
18. Decreased expression of bone morphogenetic protein (BMP) receptor type II correlates with insensitivity to BMP-6 in human renal cell carcinoma cells.
Kim IY; Lee DH; Lee DK; Kim BC; Kim HT; Leach FS; Linehan WM; Morton RA; Kim SJ
Clin Cancer Res; 2003 Dec; 9(16 Pt 1):6046-51. PubMed ID: 14676131
[TBL] [Abstract][Full Text] [Related]
19. Histone Demethylase LSD1 Regulates Kidney Cancer Progression by Modulating Androgen Receptor Activity.
Lee KH; Kim BC; Jeong SH; Jeong CW; Ku JH; Kwak C; Kim HH
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32847068
[TBL] [Abstract][Full Text] [Related]
20. Androgen receptor promotes tamoxifen agonist activity by activation of EGFR in ERα-positive breast cancer.
Ciupek A; Rechoum Y; Gu G; Gelsomino L; Beyer AR; Brusco L; Covington KR; Tsimelzon A; Fuqua SA
Breast Cancer Res Treat; 2015 Nov; 154(2):225-37. PubMed ID: 26487496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
